The MDR1 C3435T polymorphism: effects on P-glycoprotein expression/function and clinical significance.
Dresser
M J
MJ
Clinical Pharmacology, ALZA Corporation, 1950 Charleston Road, Mountain View, CA 94043, USA. mark.dresser@alza.com
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics* / Q000378:metabolism*; D002316:Cardiotonic Agents; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000627:therapeutic use; D004077:Digoxin / Q000493:pharmacokinetics; D018432:Drug Resistance, Multiple; D005838:Genotype; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D011110:Polymorphism, Genetic
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002316:Cardiotonic Agents; D007166:Immunosuppressive Agents; D004077:Digoxin; D016572:Cyclosporine